Product Dossier
SYNAREL
Product Dossier for SYNAREL (nafarelin, Pfizer). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pfizer
- Active ingredient: nafarelin
- Therapeutic area: Reproductive Health
- Same area: ESTRADOT
- Same area: PROVERA
What it is
SYNAREL is a nasal spray containing nafarelin 2 mg/mL (as acetate) as a spray solution delivered by aerosol pump actuated metered dose.
PBS listing
SYNAREL nasal spray is listed on the PBS in a 200 micrograms (as acetate) per dose strength, with 60 doses per pack. The listing comprises 2 PBS items with streamlined restricted authority required. The ex-manufacturer price is A$102.60.
Regulatory history
SYNAREL was first registered on the ARTG on 25 February 1994 under registration number ARTG 48127.